latest news releases from the newsroom
Viropro Inc. Announces Term Sheet for Financing of up to a Maximum of US $2.8 Million
MONTREAL, Feb. 2, 2005 (PRIMEZONE) -- Viropro Inc. (OTCBB:VPRO) announced today it has concluded a term sheet with Securcap Corporation to provide a convertible debenture. This financing will consolidate the financial position of Viropro for the next 18 months, thereby reinforcing the company's position during final negotiations of certain current projects. The closing on financing is expected before March 1, 2006.
Pacific Sunwear of California, Inc.
Pacific Sunwear Reports January Same Store Sales Increase 4.9 Percent
ANAHEIM, Calif., Feb. 2, 2006 (PRIMEZONE) -- Pacific Sunwear of California, Inc. (Nasdaq:PSUN) today reported that total sales for the four weeks of fiscal January, ending January 28, 2006 were $75.3 million, an increase of 15.1 percent over total sales of $65.4 million during the same period last year. Total Company same store sales increased 4.9 percent during the same period. By concept, PacSun same store sales increased 5.1 percent and d.e.m.o. same store sales increased 3.2 percent compared to the same four week period last year.
Genesis Pharmaceuticals Enterprises, Inc.
Genesis Equity Partners Acquires Interest in Chinese Real Estate Development Company
BOCA RATON, Fla., Feb. 2, 2006 (PRIMEZONE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced that its subsidiary, Genesis Equity Partners, LLC, signed a contract with The Jin Ma Group Company, Ltd., a real estate development company in Western China, to globalize its operations in the areas of real estate, construction, and hospitality. To be known as Gold Horse International, Inc., the three divisions reportedly grossed over $20 million in revenues, almost $2 million in net profits in 2005, plus net assets exceeding $10 million. Genesis Equity Partners will receive a significant equity position in Gold Horse and ongoing consulting fees for coordination and oversight of its U.S. business activities.
SmallCap Sentinel: Innovative Stem Cell Company Follows the Road Less Controversial
IRVINE, Calif., Feb. 2, 2006 (PRIMEZONE) -- Amid a society split in public opinion as to the use of embryonic stem cells, one company looks to avert that controversial hurdle with a technology based on adult stem cells. Medistem Laboratories' (OTCBB:MDSM) portfolio of biotechnology looks to capitalize on the enormous human potential of stem cell research while shedding the ethical constraints of other stem cell research fields.
SmallCap Sentinel: President Bush's State of the Union Highlights Health Care
IRVINE, Calif., Feb. 2, 2006 (PRIMEZONE) -- "President Bush's State of the Union address discussed the issue of the massive amount of Baby Boomers headed for health care," stated SmallCap Sentinel analyst D.R. Clark. "As we've said often in the pages of the SmallCap Sentinel, the horde of aging baby boomers will forever change the face of health care, biotech and the pharmaceutical industries."
Write Downs and Charges Impact Hydro's Fourth Quarter Results
OSLO, Norway, Feb. 2, 2006 (PRIMEZONE) -- Norsk Hydro ASA will record a non-cash charge in its fourth quarter 2005 results of NOK 1.8 billion (USD 270 million) before tax, corresponding to NOK 1.6 billion (USD 240 million) after tax. This charge consists of write downs in Hydro's Magnesium and Rolled Products businesses, expensing of the value of certain seismic databases acquired through the purchase of Spinnaker Exploration Company as well as a write down of the Telemark field in Gulf of Mexico.